GlassScriptPhysician profile
Sierra Moore
NPI 1215412754
$4,273.38
in general payments reported to CMS, 2019-2025
17 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.16 · 2022: $803 · 2023: $865 · 2024: $2,084 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823 · Travel and Lodging: $1,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.33 |
| Travel and Lodging | $1,594.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,694.17 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $661.11 | 2022-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $474.77 | 2022-2025 | Xtampza, Belbuca |
| Nevro Corp. | $399.27 | 2022-2024 | Senza |
| Curonix LLC | $204.35 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biotronik Nro, INC. | $161.93 | 2024-2025 | Prospera |
| Amgen INC. | $120.17 | 2022 | |
| Horizon Therapeutics Plc | $115.76 | 2023 | Krystexxa |
| Abbvie INC. | $112.70 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $82.17 | 2022-2023 | Seglentis |
| Masimo Corporation | $65.85 | 2023 | Patient Safetynet System |
| Pfizer INC. | $56.87 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $48.15 | 2025 | |
| Spr Therapeutics, INC | $22.03 | 2021-2022 | |
| Lilly USA, LLC | $20.18 | 2023 | Reyvow, Emgality |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $18.86 | 2024 | Tirosint, Licart |
| Globus Medical, INC. | $15.04 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.